Trial intelligence / Profile preview

Foster MART versus fixed-dose Foster plus salbutamol in adult asthma

2008-004671-22Phase 3Completed

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in asthma comparing Foster maintenance and reliever therapy with Fixed-dose Foster maintenance plus salbutamol reliever (2 arms). Primary endpoint: Time to first severe asthma exacerbation. Started Oct 2008; status: completed.

02

Drugs

beclometasone dipropionate + formoterolsalbutamol
03

Conditions

asthma

Beyond the preview

Go deeper on 2008-004671-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004671-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call